93 related articles for article (PubMed ID: 6365979)
1. Measurement of serum C reactive protein concentration after bone marrow transplantation for leukaemia.
Rowe IF; Worsley AM; Donnelly P; Catovsky D; Goldman JM; Galton D; Pepys MB
J Clin Pathol; 1984 Mar; 37(3):263-6. PubMed ID: 6365979
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein in the management of children with fever after allogeneic bone marrow transplantation.
de Bel C; Gerritsen E; de Maaker G; Moolenaar A; Vossen J
Infection; 1991; 19(2):92-6. PubMed ID: 2050427
[TBL] [Abstract][Full Text] [Related]
3. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period.
Walker SA; Rogers TR; Riches PG; White S; Hobbs JR
J Clin Pathol; 1984 Sep; 37(9):1018-21. PubMed ID: 6381551
[TBL] [Abstract][Full Text] [Related]
4. Serum C-reactive protein levels in the management of infection in acute leukaemia.
Starke ID; de Beer FC; Donnelly JP; Catovsky D; Goldman JM; Galton DA; Pepys MB
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):319-25. PubMed ID: 6584311
[TBL] [Abstract][Full Text] [Related]
5. Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period.
Walker SA; Riches PG; Rogers TR; White S; Hobbs JR
J Clin Pathol; 1984 Sep; 37(9):1022-6. PubMed ID: 6381552
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.
Uguccioni M; Meliconi R; Lalli E; Nesci S; Delfini C; Lucarelli G; Gasbarrini G; Facchini A
J Clin Pathol; 1992 Apr; 45(4):348-51. PubMed ID: 1577974
[TBL] [Abstract][Full Text] [Related]
7. Serum cytokine levels in patients undergoing bone marrow transplantation.
Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
[TBL] [Abstract][Full Text] [Related]
8. Lymphokines and the acute-phase response in clinical bone marrow transplantation.
Cohen J; Bayston K
Eur Cytokine Netw; 1990; 1(4):251-5. PubMed ID: 1716489
[TBL] [Abstract][Full Text] [Related]
9. Increased hepatocyte growth factor in serum in acute graft-versus-host disease.
Okamoto T; Takatsuka H; Fujimori Y; Wada H; Iwasaki T; Kakishita E
Bone Marrow Transplant; 2001 Jul; 28(2):197-200. PubMed ID: 11509938
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of C-reactive protein levels in children with bone marrow transplantation].
Pintér E; Kriván G
Orv Hetil; 1996 Jun; 137(23):1259-62. PubMed ID: 8757096
[TBL] [Abstract][Full Text] [Related]
11. Transferrin in disease. I: A potential prognostic indicator in patients undergoing bone marrow transplantation.
Hunter RL; Bennett B; Garrison C; Winton EF; Vogler WR
Am J Clin Pathol; 1984 May; 81(5):581-5. PubMed ID: 6372429
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C
Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383
[TBL] [Abstract][Full Text] [Related]
13. Changes in plasma beta 2 microglobulin concentrations after allogeneic bone marrow transplantation.
Norfolk DR; Forbes MA; Cooper EH; Child JA
J Clin Pathol; 1987 Jun; 40(6):657-62. PubMed ID: 3301908
[TBL] [Abstract][Full Text] [Related]
14. Changes in plasma fibronectin during allogeneic bone marrow transplantation.
Norfolk DR; Bowen M
J Clin Pathol; 1985 Oct; 38(10):1185-8. PubMed ID: 3902903
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha associated with chronic graft-versus-host disease in bone marrow transplantation recipients.
Fujii Y; Kaku K; Kaneko T
Bone Marrow Transplant; 1992 Aug; 10(2):194-5. PubMed ID: 1525611
[No Abstract] [Full Text] [Related]
16. Increased serum IgE concentrations during infection and graft versus host disease after bone marrow transplantation.
Walker SA; Rogers TR; Perry D; Hobbs JR; Riches PG
J Clin Pathol; 1984 Apr; 37(4):460-2. PubMed ID: 6368605
[TBL] [Abstract][Full Text] [Related]
17. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
[TBL] [Abstract][Full Text] [Related]
18. Serum interferon-gamma and C-reactive protein levels as predictors of acute graft-vs-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients.
Lange A; Karabon L; Klimczak A; Dłubek D; Bogunia-Kubik K; Swider C; Suchnicki K
Transplant Proc; 1996 Dec; 28(6):3522-5. PubMed ID: 8962369
[No Abstract] [Full Text] [Related]
19. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
20. Objective monitoring of graft-versus-host disease: alpha 1-antichymotrypsin concentration changes after bone marrow transplantation in patients developing graft-versus-host reactions.
Kamiguchi H; Ohkubo T; Yamamura M; Katsunuma T
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):165-8. PubMed ID: 3914740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
